Home Clinical Topics FDA approves Raplixa to help control bleeding during surgery

FDA approves Raplixa to help control bleeding during surgery

On April 30, the U.S. Food and Drug Administration (FDA) approved Raplixa (fibrin sealant [human]), the first spray-dried fibrin sealant approved by the agency. Raplixa is used to help control intraoperative bleeding. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here